Nevirapine and the Quest to End Pediatri

Kort om boken

In 1999, investigators announced that a single dose of nevirapine, a new antiviral drug, could stop the spread of the AIDS virus from infected mothers to their newborn babies. It was a discovery that "changed the face of AIDS globally" but it came a…

Oppdag mer

Velg tagger...
Spar {0}
Spar {0} som ARK-VENN
{0} til nettpris
med Klikk&Hent
Format/språk
   Klikk og hent - få varen innen 2 timer*
   Alltid bytterett - Norges beste. Bytt uten kvittering.
* Gjelder varer på lager i butikk

    Om Nevirapine and the Quest to End Pediatri

    In 1999, investigators announced that a single dose of nevirapine, a new antiviral drug, could stop the spread of the AIDS virus from infected mothers to their newborn babies. It was a discovery that "changed the face of AIDS globally" but it came at a high price, after years of scientific research, political conflict, social unrest and the loss of many thousands of lives. This book is the historical account of pediatric AIDS from the first reported cases in the early 1980s to the first effective treatments in the 1990s and then to the prevention of HIV infections altogether. It also includes the firsthand accounts and experiences of children infected with HIV, their families and the physicians who treated them, as well as the scientists who sought to understand the virus, discovered nevirapine's unique properties, and worked tirelessly to get it to the patients who needed it.

    Kundevurderinger

    Totalvurdering: 

    Gi din vurdering: 
    Totalvurdering: 

    Detaljer

    Format
    E-Bok
    Kopisperre
    Teknisk DRM
    Filformat
    ePUB
    Utgivelsesår
    2014
    Forlag
    McFarland & Company, Inc., Pub
    Språk
    Engelsk
    ISBN
    9781476613840
    Sider
    328

    Anbefalt